|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
|
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| CURRENT ASSETS | |||||||
| Cash and cash equivalents | |||||||
| Prepaid expenses | |||||||
| Restricted cash | |||||||
| Marketable securities | |||||||
| Accounts receivable, net | |||||||
| Inventories | |||||||
| Prepaid expenses and other current assets | |||||||
| Deferred contract costs, current | |||||||
| Forward purchase receivable | |||||||
| TOTAL CURRENT ASSETS | |||||||
| Investments held in Trust Account | |||||||
| Property and equipment, net | |||||||
| Unbilled receivables | |||||||
| Forward purchase receivable | |||||||
| Operating lease right-of-use asset | |||||||
| Goodwill | |||||||
| Prepaid expenses, noncurrent | |||||||
| Deferred contract costs, noncurrent | |||||||
| Other long-term assets | |||||||
| TOTAL ASSETS | |||||||
| LIABILITIES AND STOCKHOLDERS’ DEFICIT | |||||||
| CURRENT LIABILITIES | |||||||
| Accounts payable | |||||||
| Accrued expenses | |||||||
| Franchise tax payable | |||||||
| Deferred revenue | |||||||
| Operating lease liabilities, current | |||||||
| Other current liabilities | |||||||
| Term loan – current portion | |||||||
| Earnout liability, current | |||||||
| SPAC warrant liabilities | |||||||
| Warrants to purchase common shares | |||||||
| Warrants to purchase preferred shares | |||||||
| Forward purchase option derivative | |||||||
| TOTAL CURRENT LIABILITIES | |||||||
| Derivative warrant liabilities | |||||||
| PIPE Convertible Notes, net of transaction costs | |||||||
| Long-term debt | |||||||
| Forward purchase option derivative | |||||||
| Earnout liability, noncurrent | |||||||
| Operating lease, liability, noncurrent | |||||||
| Other long-term liabilities | |||||||
| TOTAL LIABILITIES | |||||||
| CONVERTIBLE PREFERRED STOCK (Refer to Note 13) | |||||||
| Class A Common Stock Subject to Redemption | |||||||
| TOTAL CONVERTIBLE PREFERRED STOCK (Refer to Note 13) | |||||||
| STOCKHOLDERS’ DEFICIT | |||||||
| Common stock, $0.0001 par value per share; 600,000,000 shares authorized as of both September 30, 2022 and December 31, 2021; 70,722,973 and 66,647,242 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively | |||||||
| Class A Common Stock Not Subject to Redemption | |||||||
| Class B Common Stock | |||||||
| Total common stock, $0.0001 par value per share; 600,000,000 shares authorized as of both September 30, 2022 and December 31, 2021; 70,722,973 and 66,647,242 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively | |||||||
| Additional paid-in capital | |||||||
| Accumulated other comprehensive income (loss) | |||||||
| Accumulated deficit | |||||||
| Class A Common Stock | |||||||
| Class A Common Stock Not Subject to Redemption | |||||||
| Total class A Common Stock | |||||||
| Class B Common Stock | |||||||
| TOTAL STOCKHOLDERS’ DEFICIT | |||||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT |
Loading...